Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 19, 2019

Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
J. Natl. Cancer Inst 2019 Jan 30;[EPub Ahead of Print], I Kramer, M Schaapveld, HSA Oldenburg, GS Sonke, D McCool, FE van Leeuwen, KK Van de Vijver, NS Russell, SC Linn, S Siesling, CW Menke-van der Houven van Oordt, MK Schmidt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading